Seoul Pharma Co., Ltd. (018680) Price & Analysis

― Followers

018680 Stock Chart & Stats

₩1977.00

-₩15.00(-0.75%)

Aug 24, 2026

―

Day’s Range― - ―

52-Week Range₩1,820.00 - ₩3,330.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)8.31K

Market Cap

₩23.23B

Enterprise Value₩23.13K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)13.3

Beta0.09

Next Earnings

Nov 13, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-27.25

Shares Outstanding11,659,319

10 Day Avg. Volume6,896

30 Day Avg. Volume8,314

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

018680 FAQ

What was Seoul Pharma Co., Ltd.’s price range in the past 12 months?

Seoul Pharma Co., Ltd. lowest stock price was ₩1820.00 and its highest was ₩3330.00 in the past 12 months.

What is Seoul Pharma Co., Ltd.’s market cap?

Seoul Pharma Co., Ltd.’s market cap is ₩23.23B.

When is Seoul Pharma Co., Ltd.’s upcoming earnings report date?

Seoul Pharma Co., Ltd.’s upcoming earnings report date is Nov 13, 2026 which is in 80 days.

How were Seoul Pharma Co., Ltd.’s earnings last quarter?

Seoul Pharma Co., Ltd. released its earnings results on Aug 14, 2026. The company reported -₩27.248 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Seoul Pharma Co., Ltd. overvalued?

According to Wall Street analysts Seoul Pharma Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Seoul Pharma Co., Ltd. pay dividends?

Seoul Pharma Co., Ltd. does not currently pay dividends.

What is Seoul Pharma Co., Ltd.’s EPS estimate?

Seoul Pharma Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Seoul Pharma Co., Ltd. have?

Seoul Pharma Co., Ltd. has 11,659,319 shares outstanding.

What happened to Seoul Pharma Co., Ltd.’s price movement after its last earnings report?

Seoul Pharma Co., Ltd. reported an EPS of -₩27.248 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.051%.

Which hedge fund is a major shareholder of Seoul Pharma Co., Ltd.?

Currently, no hedge funds are holding shares in KR:018680

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology